Relationship between the lymphocyte to Creactive protein ratio and coronary artery disease severity

Ke Chen1,2, Yehong Liu1,2, Baida Xu1,2

  • 1Department of Cardiology, Wuxi Clinical College of Anhui Medical University, Wuxi, Jiangsu 214044, P.R. China.

Insights

The new lymphocyte-to-C-reactive protein ratio (LCR) is a protective factor against coronary artery disease (CAD) development and severity. Higher LCR levels indicate a reduced risk of CAD, suggesting its potential as a biomarker.

Area of Science:

  • Cardiology
  • Immunology
  • Biochemistry

Background:

  • Coronary atherosclerosis is a chronic inflammatory condition.
  • Inflammatory markers like NLR, PLR, and SII are used to assess CAD severity.
  • The lymphocyte-to-C-reactive protein ratio (LCR) is a novel inflammatory index with unclear association with CAD.

Purpose of the Study:

  • To investigate the relationship between LCR and the development and severity of coronary artery disease (CAD).
  • To evaluate LCR as a potential biomarker for CAD risk and progression.

Main Methods:

  • A cohort of 1,107 patients undergoing coronary angiography was analyzed.
  • Blood samples were assessed for routine and biochemical indices, including LCR, SII, NLR, and PLR.
  • Propensity score matching (PSM) and logistic regression models were employed to analyze LCR's association with CAD and its severity.

Main Results:

  • After PSM, LCR was identified as an independent protective factor against CAD development.
  • In the coronary heart disease severity analysis, LCR also emerged as an independent protective factor.
  • Platelet count was an independent risk factor for CAD, while NLR and PLR were risk factors for CAD severity.

Conclusions:

  • The lymphocyte-to-C-reactive protein ratio (LCR) is an independent protective factor for both the development and severity of coronary artery disease.
  • LCR demonstrates potential as a valuable biomarker in assessing CAD risk and progression.